An AI-powered medical conversation assistant that records doctor-patient consult — Scored 77/100 on IdeaRoast
The Idea
An AI-powered medical conversation assistant that records doctor-patient consultations (with consent) and generates two outputs: a clinical SOAP note for the doctor and a patient-friendly summary covering diagnosis, medications, reasoning, and follow-up actions. Built for the Indian market with multilingual support including Hindi-English code-switching and regional languages. Over time, it builds a longitudinal health memory for patients — a searchable timeline of every visit, prescription, and doctor's advice — solving the universal problem that patients forget 40-80% of what doctors tell them and doctors lose continuity across visits.
The Roast
You've basically described Abridge with a Hindi accent — ambient AI scribes are already a billion-dollar market with massive players like Ambience ($243M Series C) and Suki ($168M total funding) crushing it. Your 'universal problem' of patients forgetting medical advice is being solved by everyone from Eka Care to Medoriax right here in India, complete with multilingual support.
Score Breakdown (77/100)
- Market Demand: 16/100
- Timing: 13/100
- Problem Urgency: 14/100
- Scalability: 10/100
- Competitive Moat: 5/100
- Revenue Clarity: 8/100
- Customer Access: 5/100
- Feasibility: 6/100
Strengths
- Perfect timing for India's digital healthcare push with government support
- Longitudinal health memory feature could create strong patient retention
Risks
- Saturated market with well-funded incumbents already offering identical features
- Data privacy and consent challenges in India's complex healthcare ecosystem
- Regulatory hurdles for recording patient conversations at scale
Market Intelligence
Ambience raised $243 million in Series C funding at a $1.25 billion valuation in July 2025, while Abridge raised $250 million in February and both Ambience and Suki announced $70 million fundraises in 2024. Multiple AI medical scribes specifically targeting India already exist, including Medoriax, EkaScribe (built on proprietary LLM 'Parrotlet'), and CareScribe, all offering multilingual support for Hindi-English code-switching and regional languages. The AI in medical scribing market is projected to grow from $1.67 billion in 2026 to $8.93 billion by 2035 at 20.48% CAGR.
Recommendation
Test your multilingual accuracy against EkaScribe and Medoriax with real Hindi-English code-switching scenarios in 3-5 Indian clinics. Focus on proving your longitudinal memory creates measurably better health outcomes versus existing solutions. Talk to doctors at Max Healthcare, Apollo, or Fortis about their current AI scribe pilot programs.